News & Comment

Filter By:

  • COVID-19 has not affected all scientists equally. A survey of principal investigators indicates that female scientists, those in the ‘bench sciences’ and, especially, scientists with young children experienced a substantial decline in time devoted to research. This could have important short- and longer-term effects on their careers, which institution leaders and funders need to address carefully.

    • Kyle R. Myers
    • Wei Yang Tham
    • Dashun Wang
    Comment
  • Bias and racism in the biomedical community thwart scientific advancement, reduce the pipeline of diverse clinicians and scientists, and contribute to racial and ethnic health disparities. We advocate for proactive antiracism approaches to eliminate barriers impacting people of colour, promote equity and achieve a more effective biomedical community.

    • Uraina S. Clark
    • Yasmin L. Hurd
    Comment
  • Do purchasable randomised reward mechanisms in video games (loot boxes) constitute gambling? Opinions often rest on whether virtual items obtained from loot boxes have real-world value. Using market data from real transactions, we show that virtual items have real-world monetary value and therefore could be regulated under existing gambling legislation.

    • Aaron Drummond
    • James D. Sauer
    • Malcolm R. Loudon
    Comment
  • The scientific community’s response to COVID-19 has resulted in a large volume of research moving through the publication pipeline at extraordinary speed, with a median time from receipt to acceptance of 6 days for journal articles. Although the nature of this emergency warrants accelerated publishing, measures are required to safeguard the integrity of scientific evidence.

    • Adam Palayew
    • Ole Norgaard
    • Jeffrey V. Lazarus
    Comment
  • This issue features four replication studies. Regardless of their outcome, these studies demonstrate that rigorous replication efforts invariably succeed at improving our state of knowledge and moving fields forward.

    Editorial
  • Most people in the Western, developed world prefer natural things, especially foods. We posit that there is neither theoretical nor empirical support for the widespread beliefs about the superiority of natural entities with respect to human welfare. Nature is not particularly benevolent.

    • Sydney E. Scott
    • Paul Rozin
    Comment
  • Insight into human behaviour is key to understanding both the systemic causes of the COVID-19 pandemic and how we can act to mitigate its impacts. Both now and in its wake, we have the capacity to shape and reshape the world we live in.

    Editorial
  • Prereg posters are conference posters that present planned scientific projects. We provide preliminary evidence for their value in receiving constructive feedback, promoting open science and supporting early-career researchers.

    • Kimberly Brouwers
    • Anne Cooke
    • Roni Tibon
    Comment
  • Selfless motivations for charitable giving are often represented as being superior to selfish ones. But, we argue, evidence from the behavioural sciences suggests that such a ‘hierarchy of charity’ may stand in the way of what ultimately matters: generating the most impactful giving overall.

    • Kate M. Laffan
    • Paul H. Dolan
    Comment
  • There is no business-as-usual during this uniquely challenging time. Here is what we are doing to help the scientific community both in providing much needed evidence to guide policy and in managing the personal impacts of the pandemic on individual researchers.

    Editorial
  • The debate over whether autocracies or democracies are better at fighting epidemics is misguided. Under President Xi Jinping’s centralized command, his administration has both succeeded and failed at handling the COVID-19 crisis. While it effectively curbed infections within China after the virus had spread, it failed to stem the outbreak before it went global.

    • Yuen Yuen Ang
    Comment
  • COVID-19 has started to reach Africa, a continent that has in recent decades faced the ongoing HIV/AIDS pandemic and the Ebola epidemic of 2014–2016. Dr Matshidiso Moeti, WHO Regional Director for Africa, talks to Nature Human Behaviour about the African response to COVID-19.

    • Charlotte Payne
    Q&A
  • Growth-at-any-cost economics has health costs, a reality the COVID-19 pandemic brings into sharp relief. Governments must manage the tension between economics and health, but they should not stray from their original mandate to protect people. Too much dependence on the private sector weakened pandemic response, argues Susan Erikson.

    • Susan Erikson
    World View
  • The stock market provides a view of what investors expect for the future. It is precisely in complex situations such as the COVID-19 outbreak that the prescience of the market is particularly valuable, argues Alexander F. Wagner.

    • Alexander F. Wagner
    World View